Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy
Authors Jayaraj R, Kumarasamy C, Sabarimurugan S, Samiappan S
Received 25 December 2018
Accepted for publication 7 March 2019
Published 18 April 2019 Volume 2019:11 Pages 3349—3350
Checked for plagiarism Yes
Editor who approved publication: Dr Rituraj Purohit
Rama Jayaraj,1 Chellan Kumarasamy,2 Shanthi Sabarimurugan,3 Suja Samiappan4
1College of Health and Human Sciences, Charles Darwin University, Casuarina, Northern Territory 0909, Australia; 2University of Adelaide, Adelaide, South Australia 5005, Australia; 3School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India; 4Department of Biochemistry, Bharathiar University, Coimbatore, Tamil Nadu, India
Zhang and colleagues have conducted a network meta-analysis regarding fulvestrant combined targeted therapies for breast cancer, which has been published in the Cancer Management and Research journal.1 The study itself is interesting in its approach.
View the original paper by Zhang and colleagues.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]